Indonesia Plays Blame Game After 159 Children Died in Drug Poisoning

One of the pharma companies that received sanction is Yarindo Farmatama. Their medicines are found to contain excessive EG and DEG.

The manager of Yarindo Farmatama, Vitalis Jebarus, has questioned BPOM for issuing distribution permits for their syrup medicine.

Vitalis said the company has not changed the drug composition. He said BPOM should not have issued a permit if there was a mistake.

"No change in drug composition," said Vitalis during a press conference in Serang, Banten Province.

Moreover, Vitalis said his company has registered the drug three times with BPOM. The current distribution permit is for the 2020-2025 period.

"That means BPOM itself gives supervision," said Vitalis.

Vitalis said the company is actually the victim from fraud and counterfeit whether from the supplier or from the manufacturing sides.

BPOM found the contamination of EG within Yarindo's drug is 480 times more than the standard. The usage of PG from the company is also said to exceed the limit.r

The spokesperson of the Ministry of Health, Mohammad Syahril said that the supervision for the drug syrups are under BPOM's jurisdiction.

"Actually this is the responsibility of BPOM. So, BPOM is working on the registration, testing, and supervising. That is their authority," said Mohammad Syahril during a press conference in Jakarta, Tuesday (1/11).

He declined to give further comment about the legal matters regarding the pharma companies.

There are three companies whose products are found contaminated with EG and DG, namely the Universal Pharmaceutical Industries, the Afi Pharma, and then Yarindo Farmatama.

The Ministry of Health also said that the cases of acute kidney disease are decreasing between 18 October and 28 October after they restricted the sales of drug syrup.

Previously, Syahril said the ministry could find up to 100 cases, but recently they only find five cases or fewer.

"Very, very decreasing," he said.

Fitri Haryanti Harsono, Ilyas Istianur Praditya, and Ade Nasihudin Al Ansori contributed to this report.